Zurich / Melbourne, November 2015: Venture Valuations Biotechgate and AusBiotech, the Australian Biotech Industry Association, have entered into an agreement to create a comprehensive directory of Australian biotechnology and life science companies and extend the network and reach of Biotechgate.
The Australian Life Sciences Directory will have a standalone web address and will also be a part of the larger Biotechgate global life science database (www.biotechgate.com), which includes more than 35,000 company profiles. Thanks to a comprehensive search form and automated alerts, it allows users to seek for specific companies filtering by sectors, indications, product phase and many other categories. Biotechgate produces directories for the largest life sciences clusters in the world, including BioCom in San Diego, Canada, France, Germany, Maryland, Sweden, Switzerland and UK.
Dr Anna Lavelle, CEO of Ausbiotech said: “We are pleased to be able to deliver this initiative in support of Australian biotech companies. Support tools like this new Australian directory help sector growth by enabling communication, linkages and access.”
Dr Patrik Frei, CEO of Venture Valuation said: “Increasing our Australian exposure has been important in the last 18 months and we are very happy to have one of the world’s most important biotech clusters as a partner. The database will help to provide foreign companies better access to innovative companies in Australia.”
The Biotechgate Database is the property of Venture Valuation AG, Switzerland. Biotechgate is a global life science database providing the user with information on life science companies, licensing products, financing rounds as well as key data on management structures and technology platforms. It also contains a database on licensing deals and associated financial information on individual deals.
The Australian Life Sciences Directory will be initially set up with publicly available information via company websites and once launched and live, companies will be able to log in and update and tailor their details.
Patrik Frei, CEO Venture Valuation (on the left) is signing the contract with Glenn Cross, COO AusBiotech.
The Biotechgate Database is property of Venture Valuation AG, Switzerland. Biotechgate is a global Life Science Database containing over 35,000 company profiles and providing the user with information on life science companies, licensing products, financing rounds as well as key data on management structures and technology platforms. It also contains a database on licensing deals and associated financial information on individual deals.
Venture Valuation AG (www.venturevaluation.com)
Venture Valuation specializes in independent, third party assessment, valuation and monitoring of emerging life sciences companies (biotechnology, med-tech and pharma). Services are provided in the form of independent Valuation Reports to entrepreneurs (seed to pre-IPO) and investors. With offices in Switzerland (Europe), Canada (North America) and Singapore (APAC), Venture Valuation has an experienced team of scientists and business professionals with expertise in finance, biotechnology, pharmaceutical and high technology industries.
For further information, please contact: Patrik Frei, CEO Venture Valuation, email@example.com | +41 43 321 8660